ReviewJournal of Alzheimer's disease reports
Comprehensive and stratified meta-analysis of diffusion tensor image analysis along the perivascular space in Alzheimer's disease: Linking glymphatic dysfunction with cognitive decline and amyloid pathology.
Review in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The glymphatic system clears brain waste, including amyloid-β (Aβ), and it is shown that its dysfunction may contribute to Alzheimer's disease (AD) pathology. This dysfunction can be evaluated using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) index. Objective: This study summarizes the AD literature on the glymphatic system evaluated through neuroimaging methods. Methods: We searched PubMed, Scopus, Embase, and Web of Science databases to find relevant neuroimaging studies. Results: 24 studies were included in this systematic review and meta-analysis. We observed a significant reduction in DTI-ALPS index among patients with AD, compared to healthy controls (standardized mean difference (SMD) of -1.044 (95% CI: -1.304, -0.784) in DTI studies with 1000 s/mm2 b-values and an SMD of -1.063 (95% CI: -1.278, -0.847) in studies with b-value of 2000 s/mm2). Moreover, our study reflected a significant correlation between the DTI-ALPS index and cognitive function assessed by Mini-Mental State Examination (95% CI: 0.37 to 0.51, z-score: 0.44), Montreal Cognitive Assessment (95% CI: 0.45 to 0.61, z-score: 0.54), and Clinical Dementia Rating (95% CI: -0.63 to -0.28, z-score: -0.47). Conclusions: In conclusion, our systematic review and meta-analysis revealed a significant dysfunction of the glymphatic system in patients with AD, compared to healthy participants. These findings suggest the DTI-ALPS index as a linked index to cognitive performance among patients with AD and as a potential parameter in assessing the progression of AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.